Abinash Choudhury: A Mother’s Advocacy Transforming Hemophilia Care in Nigeria
Abinash Choudhury, Associate Scientific Writer at Sanofi Global Hub, shared on LinkedIn:
”In Nigeria, undiagnosed bleeding disorders have historically led to deaths that went unrecorded.
For Megan Adediran Founder and Executive Director, Haemophilia Foundation of Nigeria, that reality became personal when her sons were diagnosed with Hemophilia A and the resources simply were not there.
So, she built them.
‘The love of a mother was my only motivation. I just wanted my son[s] to live.’
‘What started as a mother’s fight became the Haemophilia Foundation of Nigeria, directly confronting the systemic barriers that leave so many without access to diagnosis or care.’
This World Hemophilia Day, Megan‘s story reminds us why this year’s theme, ‘Diagnosis, first step to care,’ is a challenge to everyone working across health systems, policy, and advocacy to close the gaps that still exist.
We are proud to partner with the World Federation of Hemophilia to advance equitable, sustainable access to care for people with hemophilia globally.
See how we are working to make that a reality.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Sep 27, 2026, 09:03Tareq Abadl: Hemoglobin Electrophoresis Patterns Across Thalassemia Syndromes
-
Sep 27, 2026, 08:33Vincent Serra: Beyond Oncology The Expanding Landscape of Immunotherapy
-
Sep 27, 2026, 08:18Tanmoy Debnath: Multiplexed Genetic Screening From a Single Newborn Blood Spot
-
Sep 27, 2026, 07:57Christopher D: Personalized CRISPR Therapy and the Future of Rare Disease Care
-
Sep 27, 2026, 07:27Alexander Misono: Chronic Deep Vein Thrombosis and the Impact of Delayed Treatment
-
Sep 27, 2026, 07:17Emma Copperwaite: Back to BBTS With New Research and New Ideas
-
Sep 27, 2026, 05:58Alefiya B.: Imagine Treating a Genetic Disorder by Giving Cells the Instructions They are Missing
-
Sep 27, 2026, 04:5310 Posts Not to Miss This Week
-
Sep 27, 2026, 03:23Massimo Martino: VEN-DEC-GITMO – Advancing AML Treatment in Older Patients